{"transactions":[{"id":729058,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-06-23T21:23:55.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":14950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options were granted on June 18, 2026. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2027."}],"balance_after":14950,"derivative":{"exercise_price":34.16,"expiration_date":"2036-06-18","underlying":"Common stock","underlying_shares":14950},"source":{"system":"sec-edgar","filing":"0001439222-26-000103","document":"wk-form4_1782249832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000103/wk-form4_1782249832.xml","form_type":"4"}},{"id":729057,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2026-06-23T21:23:55.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":2927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on June 18, 2026. The shares underlying the stock units will vest in full on June 18, 2027. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on June 18, 2026. The shares underlying the stock units will vest in full on June 18, 2027. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":2927,"derivative":{"underlying":"Common stock","underlying_shares":2927},"source":{"system":"sec-edgar","filing":"0001439222-26-000103","document":"wk-form4_1782249832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000103/wk-form4_1782249832.xml","form_type":"4"}},{"id":729056,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2026-06-23T21:23:55.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":2816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":2816},"source":{"system":"sec-edgar","filing":"0001439222-26-000103","document":"wk-form4_1782249832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000103/wk-form4_1782249832.xml","form_type":"4"}},{"id":729055,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2026-06-23T21:23:55.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":2816,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10284,"source":{"system":"sec-edgar","filing":"0001439222-26-000103","document":"wk-form4_1782249832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922226000103/wk-form4_1782249832.xml","form_type":"4"}},{"id":746452,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-08T20:17:00.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2027 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":75000,"derivative":{"exercise_price":3.06,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001628280-26-041566","document":"wk-form4_1780949818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000162828026041566/wk-form4_1780949818.xml","form_type":"4"}},{"id":1074884,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:06.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":45000,"derivative":{"exercise_price":4.04,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001894562-25-000046","document":"wk-form4_1754440982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000046/wk-form4_1754440982.xml","form_type":"4"}},{"id":1074883,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:06.000Z","date":"2025-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":7.68,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001894562-25-000046","document":"wk-form4_1754440982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000046/wk-form4_1754440982.xml","form_type":"4"}},{"id":1074882,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:06.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":39062,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":39062,"derivative":{"exercise_price":4.04,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":39062},"source":{"system":"sec-edgar","filing":"0001894562-25-000046","document":"wk-form4_1754440982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000046/wk-form4_1754440982.xml","form_type":"4"}},{"id":1074881,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:06.000Z","date":"2025-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":39062,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":14.83,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":39062},"source":{"system":"sec-edgar","filing":"0001894562-25-000046","document":"wk-form4_1754440982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000046/wk-form4_1754440982.xml","form_type":"4"}},{"id":1074880,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:06.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":9006,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":9006,"derivative":{"exercise_price":4.04,"expiration_date":"2032-10-19","underlying":"Common Stock","underlying_shares":9006},"source":{"system":"sec-edgar","filing":"0001894562-25-000046","document":"wk-form4_1754440982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000046/wk-form4_1754440982.xml","form_type":"4"}},{"id":1074879,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:06.000Z","date":"2025-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9006,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2032-10-19","underlying":"Common Stock","underlying_shares":9006},"source":{"system":"sec-edgar","filing":"0001894562-25-000046","document":"wk-form4_1754440982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000046/wk-form4_1754440982.xml","form_type":"4"}},{"id":1074878,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:06.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":13510,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":13510,"derivative":{"exercise_price":4.04,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":13510},"source":{"system":"sec-edgar","filing":"0001894562-25-000046","document":"wk-form4_1754440982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000046/wk-form4_1754440982.xml","form_type":"4"}},{"id":1074877,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-08-06T00:43:06.000Z","date":"2025-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13510,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective as of August 1, 2025 (the \"Repricing Date\"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the \"Repriced Options\") granted under the Issuer's 2019 Stock Option and Grant Plan, as amended (the \"2019 Plan\") and/or the 2022 Stock Option and Incentive Plan (the \"2022 Plan\" and, together with the 2019 Plan, the \"Plans\"), which reduced the per share exercise price of each Repriced Option to $4.04, representing the closing price of the Issuer's common stock on The Nasdaq Global Market on the Repricing Date (the \"Option Repricing\"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the 2019 Plan and/or the 2022 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.92,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":13510},"source":{"system":"sec-edgar","filing":"0001894562-25-000046","document":"wk-form4_1754440982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456225000046/wk-form4_1754440982.xml","form_type":"4"}},{"id":1103665,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2025-06-23T20:24:30.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":2120},"source":{"system":"sec-edgar","filing":"0001439222-25-000057","document":"wk-form4_1750710263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000057/wk-form4_1750710263.xml","form_type":"4"}},{"id":1103664,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-06-23T20:24:30.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":15768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026."}],"balance_after":15768,"derivative":{"exercise_price":35.5,"expiration_date":"2035-06-18","underlying":"Common stock","underlying_shares":15768},"source":{"system":"sec-edgar","filing":"0001439222-25-000057","document":"wk-form4_1750710263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000057/wk-form4_1750710263.xml","form_type":"4"}},{"id":1103663,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2025-06-23T20:24:30.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":2816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":2816,"derivative":{"underlying":"Common stock","underlying_shares":2816},"source":{"system":"sec-edgar","filing":"0001439222-25-000057","document":"wk-form4_1750710263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000057/wk-form4_1750710263.xml","form_type":"4"}},{"id":1103662,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-06-23T20:24:30.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7468,"source":{"system":"sec-edgar","filing":"0001439222-25-000057","document":"wk-form4_1750710263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922225000057/wk-form4_1750710263.xml","form_type":"4"}},{"id":1121569,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-05T22:13:13.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2026 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":55000,"derivative":{"exercise_price":1.32,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001628280-25-029770","document":"wk-form4_1749161364.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000162828025029770/wk-form4_1749161364.xml","form_type":"4"}},{"id":1470593,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2024-06-24T20:10:11.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":11774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 20, 2024. The shares underlying this option vest as to 100% of the underlying shares on June 20, 2025."}],"balance_after":11774,"derivative":{"exercise_price":42.45,"expiration_date":"2034-06-20","underlying":"Common stock","underlying_shares":11774},"source":{"system":"sec-edgar","filing":"0001439222-24-000105","document":"wk-form4_1719259804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000105/wk-form4_1719259804.xml","form_type":"4"}},{"id":1470592,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2024-06-24T20:10:11.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units will vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 20, 2024. The shares underlying the stock units will vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":2120,"derivative":{"underlying":"Common stock","underlying_shares":2120},"source":{"system":"sec-edgar","filing":"0001439222-24-000105","document":"wk-form4_1719259804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000105/wk-form4_1719259804.xml","form_type":"4"}},{"id":1477211,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2024-06-17T21:32:49.000Z","date":"2024-06-13","kind":"exercise","planned":false,"acquired":false,"shares":3388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on June 13, 2023. The shares underlying the stock units vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on June 13, 2023. The shares underlying the stock units vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":3388},"source":{"system":"sec-edgar","filing":"0001439222-24-000091","document":"wk-form4_1718659962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000091/wk-form4_1718659962.xml","form_type":"4"}},{"id":1477210,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-06-17T21:32:49.000Z","date":"2024-06-13","kind":"gift","planned":false,"acquired":false,"shares":3564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This disposition reflects a gift of 3,564 shares to a not-for-profit organization."}],"balance_after":5348,"source":{"system":"sec-edgar","filing":"0001439222-24-000091","document":"wk-form4_1718659962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000091/wk-form4_1718659962.xml","form_type":"4"}},{"id":1477209,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-06-17T21:32:49.000Z","date":"2024-06-13","kind":"exercise","planned":false,"acquired":true,"shares":3388,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8912,"source":{"system":"sec-edgar","filing":"0001439222-24-000091","document":"wk-form4_1718659962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000091/wk-form4_1718659962.xml","form_type":"4"}},{"id":1479382,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T20:58:56.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 12, 2025 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date"}],"balance_after":45000,"derivative":{"exercise_price":7.68,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001894562-24-000037","document":"wk-form4_1718398728.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456224000037/wk-form4_1718398728.xml","form_type":"4"}},{"id":1583987,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-03-11T20:09:27.000Z","date":"2024-03-07","kind":"sale","planned":false,"acquired":false,"shares":1285,"price":31.62,"value":40631.7,"ownership":{"direct":true},"balance_after":5524,"source":{"system":"sec-edgar","filing":"0001439222-24-000061","document":"wk-form4_1710187757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000061/wk-form4_1710187757.xml","form_type":"4"}},{"id":1588999,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-03-07T23:49:02.000Z","date":"2024-03-06","kind":"sale","planned":false,"acquired":false,"shares":4415,"price":31.99,"value":141235.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $31.99 to $32.04. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":6809,"source":{"system":"sec-edgar","filing":"0001439222-24-000058","document":"wk-form4_1709855334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000058/wk-form4_1709855334.xml","form_type":"4"}},{"id":1588998,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-03-07T23:49:02.000Z","date":"2024-03-05","kind":"sale","planned":false,"acquired":false,"shares":300,"price":32.21,"value":9663.0,"ownership":{"direct":true},"balance_after":11224,"source":{"system":"sec-edgar","filing":"0001439222-24-000058","document":"wk-form4_1709855334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922224000058/wk-form4_1709855334.xml","form_type":"4"}},{"id":1809841,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2023-08-11T20:04:51.000Z","date":"2023-08-09","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 21, 2022. The shares underlying this option vest as to 100% of the underlying shares on June 21, 2023."}],"balance_after":4307,"derivative":{"exercise_price":18.09,"expiration_date":"2032-06-21","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001439222-23-000125","document":"wk-form4_1691784273.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000125/wk-form4_1691784273.xml","form_type":"4"}},{"id":1809840,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-08-11T20:04:51.000Z","date":"2023-08-09","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":25.9555,"value":648887.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $25.69 to $26.37. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":11524,"source":{"system":"sec-edgar","filing":"0001439222-23-000125","document":"wk-form4_1691784273.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000125/wk-form4_1691784273.xml","form_type":"4"}},{"id":1809839,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-08-11T20:04:51.000Z","date":"2023-08-09","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":18.09,"value":452250.0,"ownership":{"direct":true},"balance_after":36524,"source":{"system":"sec-edgar","filing":"0001439222-23-000125","document":"wk-form4_1691784273.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000125/wk-form4_1691784273.xml","form_type":"4"}},{"id":1845095,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock unit","published_at":"2023-06-23T20:38:51.000Z","date":"2023-06-21","kind":"exercise","planned":false,"acquired":false,"shares":4975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on June 21, 2022. The shares underlying the stock units will vest in full on June 21, 2023. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on June 21, 2022. The shares underlying the stock units will vest in full on June 21, 2023. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":4975},"source":{"system":"sec-edgar","filing":"0001439222-23-000097","document":"wk-form4_1687552715.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000097/wk-form4_1687552715.xml","form_type":"4"}},{"id":1845094,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-06-23T20:38:51.000Z","date":"2023-06-21","kind":"exercise","planned":false,"acquired":true,"shares":4975,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11524,"source":{"system":"sec-edgar","filing":"0001439222-23-000097","document":"wk-form4_1687552715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000097/wk-form4_1687552715.xml","form_type":"4"}},{"id":1852721,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T21:49:48.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":39062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 14, 2024 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":39062,"derivative":{"exercise_price":14.83,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":39062},"source":{"system":"sec-edgar","filing":"0001894562-23-000026","document":"wf-form4_168695217738921.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000189456223000026/wf-form4_168695217738921.xml","form_type":"4"}},{"id":1854207,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2023-06-15T20:20:25.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":18958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 13, 2023. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2024."}],"balance_after":18958,"derivative":{"exercise_price":26.56,"expiration_date":"2033-06-13","underlying":"Common stock","underlying_shares":18958},"source":{"system":"sec-edgar","filing":"0001439222-23-000073","document":"wk-form4_1686860412.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000073/wk-form4_1686860412.xml","form_type":"4"}},{"id":1854206,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2023-06-15T20:20:25.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":3388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":3388,"derivative":{"underlying":"Common stock","underlying_shares":3388},"source":{"system":"sec-edgar","filing":"0001439222-23-000073","document":"wk-form4_1686860412.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000073/wk-form4_1686860412.xml","form_type":"4"}},{"id":2052312,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-01-18T21:09:10.000Z","date":"2023-01-13","kind":"gift","acquired":false,"shares":2200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6549,"source":{"system":"sec-edgar","filing":"0001439222-23-000006","document":"wf-form4_167407612959834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922223000006/wf-form4_167407612959834.xml","form_type":"4"}},{"id":2133672,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-21T20:31:04.000Z","date":"2022-10-19","kind":"grant","acquired":true,"shares":9006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest in three equal annual installments beginning on September 13, 2022, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":9006,"derivative":{"exercise_price":17,"expiration_date":"2032-10-19","underlying":"Common Stock","underlying_shares":9006},"source":{"system":"sec-edgar","filing":"0001628280-22-026823","document":"wf-form4_166638424668882.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894562/000162828022026823/wf-form4_166638424668882.xml","form_type":"4"}},{"id":2222979,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2022-06-23T20:10:01.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":29307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 21, 2022. The shares underlying this option vest as to 100% of the underlying shares on June 21, 2023."}],"balance_after":29307,"derivative":{"exercise_price":18.09,"expiration_date":"2032-06-21","underlying":"Common stock","underlying_shares":29307},"source":{"system":"sec-edgar","filing":"0001439222-22-000062","document":"wf-form4_165601498762477.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000062/wf-form4_165601498762477.xml","form_type":"4"}},{"id":2222978,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock unit","published_at":"2022-06-23T20:10:01.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":4975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on June 21, 2022. The shares underlying the stock units will vest in full on June 21, 2023. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on June 21, 2022. The shares underlying the stock units will vest in full on June 21, 2023. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":4975,"derivative":{"underlying":"Common stock","underlying_shares":4975},"source":{"system":"sec-edgar","filing":"0001439222-22-000062","document":"wf-form4_165601498762477.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000062/wf-form4_165601498762477.xml","form_type":"4"}},{"id":2258107,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock unit","published_at":"2022-05-24T20:10:37.000Z","date":"2022-05-20","kind":"exercise","acquired":false,"shares":1585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested"}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":1585},"source":{"system":"sec-edgar","filing":"0001439222-22-000048","document":"wf-form4_165342301824518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000048/wf-form4_165342301824518.xml","form_type":"4"}},{"id":2258106,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-05-24T20:10:37.000Z","date":"2022-05-20","kind":"exercise","acquired":true,"shares":1585,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8749,"source":{"system":"sec-edgar","filing":"0001439222-22-000048","document":"wf-form4_165342301824518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000048/wf-form4_165342301824518.xml","form_type":"4"}},{"id":2686294,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2021-06-02T20:08:25.000Z","date":"2021-05-28","kind":"exercise","acquired":false,"shares":1686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":1686},"source":{"system":"sec-edgar","filing":"0001439222-21-000053","document":"wf-form4_162266448299578.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000053/wf-form4_162266448299578.xml","form_type":"4"}},{"id":2686293,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2021-06-02T20:08:25.000Z","date":"2021-05-28","kind":"exercise","acquired":true,"shares":1686,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7164,"source":{"system":"sec-edgar","filing":"0001439222-21-000053","document":"wf-form4_162266448299578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000053/wf-form4_162266448299578.xml","form_type":"4"}},{"id":2698755,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2021-05-24T20:45:01.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":8888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on May 20, 2021. The shares underlying this option vest as to 100% of the underlying shares on May 20, 2022."}],"balance_after":8888,"derivative":{"exercise_price":56.76,"expiration_date":"2031-05-20","underlying":"Common stock","underlying_shares":8888},"source":{"system":"sec-edgar","filing":"0001439222-21-000045","document":"wf-form4_162188908499200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000045/wf-form4_162188908499200.xml","form_type":"4"}},{"id":2698754,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock unit","published_at":"2021-05-24T20:45:01.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":1585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested"}],"balance_after":1585,"derivative":{"underlying":"Common stock","underlying_shares":1585},"source":{"system":"sec-edgar","filing":"0001439222-21-000045","document":"wf-form4_162188908499200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922221000045/wf-form4_162188908499200.xml","form_type":"4"}},{"id":3128952,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2020-06-01T21:13:39.000Z","date":"2020-05-29","kind":"exercise","acquired":false,"shares":1878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":1878},"source":{"system":"sec-edgar","filing":"0001439222-20-000052","document":"wf-form4_159104599634402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000052/wf-form4_159104599634402.xml","form_type":"4"}},{"id":3128951,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2020-06-01T21:13:39.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":1686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested."}],"balance_after":1686,"derivative":{"underlying":"Common stock","underlying_shares":1686},"source":{"system":"sec-edgar","filing":"0001439222-20-000052","document":"wf-form4_159104599634402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000052/wf-form4_159104599634402.xml","form_type":"4"}},{"id":3128950,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2020-06-01T21:13:39.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":8096,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 28, 2020. This option vests as to 100% of the underlying shares on May 28, 2021."}],"balance_after":8096,"derivative":{"exercise_price":53.35,"expiration_date":"2030-05-28","underlying":"Common stock","underlying_shares":8096},"source":{"system":"sec-edgar","filing":"0001439222-20-000052","document":"wf-form4_159104599634402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000052/wf-form4_159104599634402.xml","form_type":"4"}},{"id":3128949,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-06-01T21:13:39.000Z","date":"2020-05-29","kind":"exercise","acquired":true,"shares":1878,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":5478,"source":{"system":"sec-edgar","filing":"0001439222-20-000052","document":"wf-form4_159104599634402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922220000052/wf-form4_159104599634402.xml","form_type":"4"}},{"id":3506275,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2019-05-31T20:05:04.000Z","date":"2019-05-31","kind":"exercise","acquired":false,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on May 31, 2018. The shares underlying the stock units vested in full on May 31, 2019. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on May 31, 2018. The shares underlying the stock units vested in full on May 31, 2019. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001209191-19-033618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919119033618/doc4.xml","form_type":"4"}},{"id":3506274,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2019-05-31T20:05:04.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":1878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on May 29, 2019. The shares underlying the stock units will vest in full on May 29, 2020. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":1878,"derivative":{"underlying":"Common stock","underlying_shares":1878},"source":{"system":"sec-edgar","filing":"0001209191-19-033618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919119033618/doc4.xml","form_type":"4"}},{"id":3506273,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-05-31T20:05:04.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":8919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 29, 2019. The shares underlying this option vest as to 100% of the underlying shares on May 29, 2020."}],"balance_after":8919,"derivative":{"exercise_price":47.91,"expiration_date":"2029-05-29","underlying":"Common stock","underlying_shares":8919},"source":{"system":"sec-edgar","filing":"0001209191-19-033618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919119033618/doc4.xml","form_type":"4"}},{"id":3506272,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2019-05-31T20:05:04.000Z","date":"2019-05-31","kind":"exercise","acquired":true,"shares":1400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":3600,"source":{"system":"sec-edgar","filing":"0001209191-19-033618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919119033618/doc4.xml","form_type":"4"}},{"id":3890676,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-06-18T20:05:01.000Z","date":"2018-06-14","kind":"exercise","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on June 13, 2017. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2018."}],"balance_after":0,"derivative":{"exercise_price":50.73,"expiration_date":"2027-06-13","underlying":"Common stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-18-038277","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919118038277/doc4.xml","form_type":"4"}},{"id":3890675,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-06-18T20:05:01.000Z","date":"2018-06-14","kind":"sale","acquired":false,"shares":839,"price":94.3,"value":79117.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $94.21 to $94.63. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":2200,"source":{"system":"sec-edgar","filing":"0001209191-18-038277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919118038277/doc4.xml","form_type":"4"}},{"id":3890674,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-06-18T20:05:01.000Z","date":"2018-06-14","kind":"sale","acquired":false,"shares":5980,"price":93.78,"value":560804.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $93.15 to $94.13. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":3039,"source":{"system":"sec-edgar","filing":"0001209191-18-038277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919118038277/doc4.xml","form_type":"4"}},{"id":3890673,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-06-18T20:05:01.000Z","date":"2018-06-14","kind":"sale","acquired":false,"shares":2181,"price":92.62,"value":202004.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $92.14 to $93.11. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":9019,"source":{"system":"sec-edgar","filing":"0001209191-18-038277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919118038277/doc4.xml","form_type":"4"}},{"id":3890672,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-06-18T20:05:01.000Z","date":"2018-06-14","kind":"exercise","acquired":true,"shares":9000,"price":50.73,"value":456570.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":11200,"source":{"system":"sec-edgar","filing":"0001209191-18-038277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919118038277/doc4.xml","form_type":"4"}},{"id":3908240,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2018-06-04T20:17:25.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on May 31, 2018. The shares underlying the stock units will vest in full on May 31, 2019. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on May 31, 2018. The shares underlying the stock units will vest in full on May 31, 2019. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":1400,"derivative":{"underlying":"Common stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001209191-18-035041","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919118035041/doc4.xml","form_type":"4"}},{"id":3908239,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-06-04T20:17:25.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 31, 2018. The shares underlying this option vest as to 100% of the underlying shares on May 31, 2019."}],"balance_after":5700,"derivative":{"exercise_price":93.5,"expiration_date":"2028-05-30","underlying":"Common stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001209191-18-035041","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919118035041/doc4.xml","form_type":"4"}},{"id":3986353,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-03-21T20:04:30.000Z","date":"2018-03-19","kind":"exercise","acquired":false,"shares":6800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on June 21, 2016. The shares underlying this option vest as to 100% of the underlying shares on June 21, 2017."}],"balance_after":0,"derivative":{"exercise_price":47.33,"expiration_date":"2026-06-20","underlying":"Common stock","underlying_shares":6800},"source":{"system":"sec-edgar","filing":"0001209191-18-021060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919118021060/doc4.xml","form_type":"4"}},{"id":3986352,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-03-21T20:04:30.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":6800,"price":81.97,"value":557396.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is the weighted average of the shares sold.  The shares were sold at varying prices in the range of $81.53 to $82.52. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":2200,"source":{"system":"sec-edgar","filing":"0001209191-18-021060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919118021060/doc4.xml","form_type":"4"}},{"id":3986351,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-03-21T20:04:30.000Z","date":"2018-03-19","kind":"exercise","acquired":true,"shares":6800,"price":47.33,"value":321844.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-18-021060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919118021060/doc4.xml","form_type":"4"}},{"id":4027064,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-02-28T21:02:06.000Z","date":"2018-02-26","kind":"exercise","acquired":false,"shares":2200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 21, 2016. The shares underlying this option vest as to 100% of the underlying shares on June 21, 2017."}],"balance_after":6800,"derivative":{"exercise_price":47.33,"expiration_date":"2026-06-20","underlying":"Common stock","underlying_shares":2200},"source":{"system":"sec-edgar","filing":"0001209191-18-014455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919118014455/doc4.xml","form_type":"4"}},{"id":4027063,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-02-28T21:02:06.000Z","date":"2018-02-26","kind":"exercise","acquired":true,"shares":2200,"price":47.33,"value":104126.0,"ownership":{"direct":true},"balance_after":2200,"source":{"system":"sec-edgar","filing":"0001209191-18-014455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919118014455/doc4.xml","form_type":"4"}},{"id":4280651,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-06-15T21:04:37.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 13, 2017. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2018."}],"balance_after":9000,"derivative":{"exercise_price":50.73,"expiration_date":"2027-06-12","underlying":"Common stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-17-040190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000120919117040190/doc4.xml","form_type":"4"}},{"id":217973,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Phantom Stock Units","published_at":"2010-01-05T21:18:50.000Z","date":"2009-12-31","kind":"grant","acquired":true,"shares":45,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on December 31, 2009 at $64.78 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date).  Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on December 31, 2009 at $64.78 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date).  Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on December 31, 2009 at $64.78 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date).  Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time."}],"balance_after":5998,"derivative":{"underlying":"Common Stock","underlying_shares":45},"source":{"system":"sec-edgar","filing":"0000200406-10-000001","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040610000001/edgar.xml","form_type":"4"}},{"id":217972,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common","published_at":"2010-01-05T21:18:50.000Z","date":"2009-12-31","kind":"other","acquired":true,"shares":34,"ownership":{"direct":false,"nature":"Johnson & Johnson Stock Fund under the 401(k) Savings Plan"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (12/31/2009)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (12/31/2009)."}],"balance_after":1181,"source":{"system":"sec-edgar","filing":"0000200406-10-000001","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040610000001/edgar.xml","form_type":"4"}},{"id":218529,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2009-12-11T19:45:57.000Z","date":"2009-12-10","kind":"exercise","acquired":false,"shares":71992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant."}],"balance_after":0,"derivative":{"exercise_price":58.34,"exercise_date":"2009-02-14","expiration_date":"2016-02-12","underlying":"Common Stock","underlying_shares":71992},"source":{"system":"sec-edgar","filing":"0000200406-09-000142","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000142/edgar.xml","form_type":"4"}},{"id":218528,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2009-12-11T19:45:57.000Z","date":"2009-12-10","kind":"exercise","acquired":false,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant."}],"balance_after":0,"derivative":{"exercise_price":53.93,"exercise_date":"2007-02-10","expiration_date":"2014-02-07","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0000200406-09-000142","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000142/edgar.xml","form_type":"4"}},{"id":218527,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2009-12-11T19:45:57.000Z","date":"2009-12-10","kind":"exercise","acquired":false,"shares":13250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant."}],"balance_after":0,"derivative":{"exercise_price":53,"exercise_date":"2006-05-24","expiration_date":"2013-05-22","underlying":"Common Stock","underlying_shares":13250},"source":{"system":"sec-edgar","filing":"0000200406-09-000142","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000142/edgar.xml","form_type":"4"}},{"id":218526,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common","published_at":"2009-12-11T19:45:57.000Z","date":"2009-11-30","kind":"other","acquired":true,"shares":8,"ownership":{"direct":false,"nature":"Johnson & Johnson Stock Fund under the 401(k) Savings Plan"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (11/30/2009)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (11/30/2009)."}],"balance_after":1147,"source":{"system":"sec-edgar","filing":"0000200406-09-000142","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000142/edgar.xml","form_type":"4"}},{"id":218525,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common Stock","published_at":"2009-12-11T19:45:57.000Z","date":"2009-12-10","kind":"sale","acquired":false,"shares":96742,"price":64.76,"value":6265011.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $64.68 to $64.84.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4583,"source":{"system":"sec-edgar","filing":"0000200406-09-000142","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000142/edgar.xml","form_type":"4"}},{"id":218524,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common Stock","published_at":"2009-12-11T19:45:57.000Z","date":"2009-12-10","kind":"exercise","acquired":true,"shares":71992,"price":58.34,"value":4200013.28,"ownership":{"direct":true},"balance_after":101171,"source":{"system":"sec-edgar","filing":"0000200406-09-000142","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000142/edgar.xml","form_type":"4"}},{"id":218523,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common Stock","published_at":"2009-12-11T19:45:57.000Z","date":"2009-12-10","kind":"exercise","acquired":true,"shares":11500,"price":53.93,"value":620195.0,"ownership":{"direct":true},"balance_after":29179,"source":{"system":"sec-edgar","filing":"0000200406-09-000142","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000142/edgar.xml","form_type":"4"}},{"id":218522,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common","published_at":"2009-12-11T19:45:57.000Z","date":"2009-12-10","kind":"exercise","acquired":true,"shares":13250,"price":53,"value":702250.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes 819 shares held under Issuer's Dividend Reinvestment Program."}],"balance_after":17679,"source":{"system":"sec-edgar","filing":"0000200406-09-000142","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000142/edgar.xml","form_type":"4"}},{"id":221332,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Phantom Stock Units","published_at":"2009-10-02T16:57:34.000Z","date":"2009-09-30","kind":"grant","acquired":true,"shares":48,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Phantom Stock converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on September 30, 2009 at $61.15 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date).  Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on September 30, 2009 at $61.15 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date).  Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time."}],"balance_after":5953,"derivative":{"underlying":"Common Stock","underlying_shares":48},"source":{"system":"sec-edgar","filing":"0000200406-09-000111","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000111/edgar.xml","form_type":"4"}},{"id":221331,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common","published_at":"2009-10-02T16:57:34.000Z","date":"2009-09-30","kind":"other","acquired":true,"shares":9,"ownership":{"direct":false,"nature":"Johnson & Johnson Stock Fund under the 401(k) Savings Plan"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (09/30/2009)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (09/30/2009)."}],"balance_after":1139,"source":{"system":"sec-edgar","filing":"0000200406-09-000111","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000111/edgar.xml","form_type":"4"}},{"id":223999,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Phantom Stock Units","published_at":"2009-07-02T19:28:10.000Z","date":"2009-06-30","kind":"grant","acquired":true,"shares":51,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Phantom Stock converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2009 at $56.52 per share are to be settled in cash upon the Reporting Person's Retirement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2009 at $56.52 per share are to be settled in cash upon the Reporting Person's Retirement."}],"balance_after":5905,"derivative":{"underlying":"Common Stock","underlying_shares":51},"source":{"system":"sec-edgar","filing":"0000200406-09-000082","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000082/edgar.xml","form_type":"4"}},{"id":223998,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common","published_at":"2009-07-02T19:28:10.000Z","date":"2009-06-30","kind":"other","acquired":true,"shares":119,"ownership":{"direct":false,"nature":"Johnson & Johnson Stock Fund under the 401(k) Savings Plan"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (06/30/2009)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (06/30/2009)."}],"balance_after":1130,"source":{"system":"sec-edgar","filing":"0000200406-09-000082","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000082/edgar.xml","form_type":"4"}},{"id":225555,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Phantom Stock Units","published_at":"2009-04-02T19:15:33.000Z","date":"2009-03-31","kind":"grant","acquired":true,"shares":50,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Phantom Stock converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 31, 2009 at $52.82 per share are to be settled in cash upon the Reporting Person's Retirement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 31, 2009 at $52.82 per share are to be settled in cash upon the Reporting Person's Retirement."}],"balance_after":5854,"derivative":{"underlying":"Common Stock","underlying_shares":50},"source":{"system":"sec-edgar","filing":"0000200406-09-000057","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000057/edgar.xml","form_type":"4"}},{"id":225554,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common","published_at":"2009-04-02T19:15:33.000Z","date":"2009-03-31","kind":"other","acquired":true,"shares":77,"ownership":{"direct":false,"nature":"Johnson & Johnson Stock Fund under the 401(k) Savings Plan"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (03/31/2009)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (03/31/2009)."}],"balance_after":1011,"source":{"system":"sec-edgar","filing":"0000200406-09-000057","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000057/edgar.xml","form_type":"4"}},{"id":226495,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Restricted Share Units","published_at":"2009-02-17T23:30:28.000Z","date":"2009-02-13","kind":"exercise","acquired":false,"shares":5999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 13, 2006, represents a contingent right to receive one share of Company Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Not applicable."}],"balance_after":0,"derivative":{"exercise_date":"2009-02-13","underlying":"Common","underlying_shares":5999},"source":{"system":"sec-edgar","filing":"0000200406-09-000040","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000040/edgar.xml","form_type":"4"}},{"id":226494,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Phantom Stock Units","published_at":"2009-02-17T23:30:28.000Z","date":"2009-02-12","kind":"grant","acquired":true,"shares":1579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Phantom Stock converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 12, 2009 at $56.97 per share are to be settled in cash upon the Reporting Person's Retirement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 12, 2009 at $56.97 per share are to be settled in cash upon the Reporting Person's Retirement."}],"balance_after":5804,"derivative":{"underlying":"Common Stock","underlying_shares":1579},"source":{"system":"sec-edgar","filing":"0000200406-09-000040","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000040/edgar.xml","form_type":"4"}},{"id":226493,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common","published_at":"2009-02-17T23:30:28.000Z","date":"2009-02-13","kind":"tax_withholding","acquired":false,"shares":2236,"price":57.31,"value":128145.16,"ownership":{"direct":true},"balance_after":4429,"source":{"system":"sec-edgar","filing":"0000200406-09-000040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000040/edgar.xml","form_type":"4"}},{"id":226492,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common","published_at":"2009-02-17T23:30:28.000Z","date":"2009-02-13","kind":"exercise","acquired":true,"shares":5999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares acquired under Issuer's Dividend Reinvestment Program."}],"balance_after":6665,"source":{"system":"sec-edgar","filing":"0000200406-09-000040","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000040/edgar.xml","form_type":"4"}},{"id":226653,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Restricted Share Units","published_at":"2009-02-11T22:39:42.000Z","date":"2009-02-09","kind":"grant","acquired":true,"shares":6858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The Restricted Share Units vest three years after date of grant."}],"balance_after":6858,"derivative":{"exercise_date":"2012-02-09","underlying":"Common","underlying_shares":6858},"source":{"system":"sec-edgar","filing":"0000200406-09-000027","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000027/edgar.xml","form_type":"4"}},{"id":226652,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2009-02-11T22:39:42.000Z","date":"2009-02-09","kind":"grant","acquired":true,"shares":82290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Awarded under Issuer's Long-Term Incentive Plan."}],"balance_after":82290,"derivative":{"exercise_price":58.33,"exercise_date":"2012-02-10","expiration_date":"2019-02-08","underlying":"Common","underlying_shares":82290},"source":{"system":"sec-edgar","filing":"0000200406-09-000027","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000027/edgar.xml","form_type":"4"}},{"id":226651,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common","published_at":"2009-02-11T22:39:42.000Z","date":"2009-01-30","kind":"other","acquired":true,"shares":31,"ownership":{"direct":false,"nature":"Johnson & Johnson Stock Fund under the 401(k) Savings Plan"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (01/30/2009)."}],"balance_after":934,"source":{"system":"sec-edgar","filing":"0000200406-09-000027","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000027/edgar.xml","form_type":"4"}},{"id":227614,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Phantom Stock Units","published_at":"2009-01-05T19:41:42.000Z","date":"2008-12-31","kind":"other","acquired":true,"shares":33,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on December 31, 2008 at $58.73 per share are to be settled in cash upon the Reporting Person's Retirement."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Phantom Stock converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on December 31, 2008 at $58.73 per share are to be settled in cash upon the Reporting Person's Retirement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on December 31, 2008 at $58.73 per share are to be settled in cash upon the Reporting Person's Retirement."}],"balance_after":4225,"derivative":{"underlying":"Common Stock","underlying_shares":33},"source":{"system":"sec-edgar","filing":"0000200406-09-000001","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000001/edgar.xml","form_type":"4"}},{"id":227613,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common","published_at":"2009-01-05T19:41:42.000Z","date":"2008-12-31","kind":"other","acquired":true,"shares":8,"ownership":{"direct":false,"nature":"401(k) and ESOP Savings Plans"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (12/31/2008)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (12/31/2008)."}],"balance_after":936,"source":{"system":"sec-edgar","filing":"0000200406-09-000001","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040609000001/edgar.xml","form_type":"4"}},{"id":229096,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Phantom Stock Units","published_at":"2008-10-02T13:46:53.000Z","date":"2008-09-30","kind":"other","acquired":true,"shares":28,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on September 30, 2008 at $68.38 per share are to be settled in cash upon the Reporting Person's Retirement."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Phantom Stock converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on September 30, 2008 at $68.38 per share are to be settled in cash upon the Reporting Person's Retirement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on September 30, 2008 at $68.38 per share are to be settled in cash upon the Reporting Person's Retirement."}],"balance_after":4192,"derivative":{"underlying":"Common Stock","underlying_shares":28},"source":{"system":"sec-edgar","filing":"0000200406-08-000135","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040608000135/edgar.xml","form_type":"4"}},{"id":229095,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common","published_at":"2008-10-02T13:46:53.000Z","date":"2008-09-30","kind":"other","acquired":true,"shares":23,"ownership":{"direct":false,"nature":"401(k) and ESOP Savings Plans"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (09/30/2008)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (09/30/2008)."}],"balance_after":928,"source":{"system":"sec-edgar","filing":"0000200406-08-000135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040608000135/edgar.xml","form_type":"4"}},{"id":232692,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Phantom Stock Units","published_at":"2008-07-01T22:15:20.000Z","date":"2008-06-30","kind":"other","acquired":true,"shares":30,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2008 at $64.06 per share are to be settled in cash upon the Reporting Person's Retirement."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Phantom Stock converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2008 at $64.06 per share are to be settled in cash upon the Reporting Person's Retirement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2008 at $64.06 per share are to be settled in cash upon the Reporting Person's Retirement."}],"balance_after":4164,"derivative":{"underlying":"Common Stock","underlying_shares":30},"source":{"system":"sec-edgar","filing":"0000200406-08-000102","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040608000102/edgar.xml","form_type":"4"}},{"id":232691,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common","published_at":"2008-07-01T22:15:20.000Z","date":"2008-05-30","kind":"other","acquired":true,"shares":71,"ownership":{"direct":false,"nature":"401(k) and ESOP Savings Plans"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (05/30/2008)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (05/30/2008)."}],"balance_after":905,"source":{"system":"sec-edgar","filing":"0000200406-08-000102","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040608000102/edgar.xml","form_type":"4"}},{"id":236378,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Phantom Stock Units","published_at":"2008-04-02T21:06:30.000Z","date":"2008-03-31","kind":"other","acquired":true,"shares":26,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 31, 2008 at $64.53 per share are to be settled in cash upon the Reporting Person's Retirement."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Phantom Stock converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 31, 2008 at $64.53 per share are to be settled in cash upon the Reporting Person's Retirement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 31, 2008 at $64.53 per share are to be settled in cash upon the Reporting Person's Retirement."}],"balance_after":4134,"derivative":{"underlying":"Common Stock","underlying_shares":26},"source":{"system":"sec-edgar","filing":"0000200406-08-000066","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040608000066/edgar.xml","form_type":"4"}},{"id":236377,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Common","published_at":"2008-04-02T21:06:30.000Z","date":"2008-03-31","kind":"other","acquired":true,"shares":59,"ownership":{"direct":false,"nature":"401(k) and ESOP Savings Plans"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (03/31/2008)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of Plans' most recent reporting date (03/31/2008)."}],"balance_after":834,"source":{"system":"sec-edgar","filing":"0000200406-08-000066","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040608000066/edgar.xml","form_type":"4"}},{"id":238601,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Phantom Stock Units","published_at":"2008-02-15T21:35:15.000Z","date":"2008-02-14","kind":"grant","acquired":true,"shares":1496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 14, 2008 at $63.13 per share are to be settled in cash upon the Reporting Person's Retirement."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Phantom Stock converts into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 14, 2008 at $63.13 per share are to be settled in cash upon the Reporting Person's Retirement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 14, 2008 at $63.13 per share are to be settled in cash upon the Reporting Person's Retirement."}],"balance_after":4108,"derivative":{"underlying":"Common Stock","underlying_shares":1496},"source":{"system":"sec-edgar","filing":"0000200406-08-000047","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040608000047/edgar.xml","form_type":"4"}},{"id":238704,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Restricted Share Units","published_at":"2008-02-13T22:39:02.000Z","date":"2008-02-11","kind":"grant","acquired":true,"shares":6073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Restricted Share Units vest three years after date of grant."}],"balance_after":6073,"derivative":{"exercise_date":"2011-02-11","underlying":"Common Stock","underlying_shares":6073},"source":{"system":"sec-edgar","filing":"0000200406-08-000038","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040608000038/edgar.xml","form_type":"4"}},{"id":238703,"issuer":{"id":2722,"kind":"organization","name":"JOHNSON & JOHNSON","symbol":"JNJ"},"owners":[{"id":13218,"kind":"person","name":"Foster-Cheek Kaye I","position":1,"cik":"0001312622","reported_name":"Foster-Cheek Kaye I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Human Resources"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2008-02-13T22:39:02.000Z","date":"2008-02-11","kind":"grant","acquired":true,"shares":72874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Awarded under Issuer's Long-Term Incentive Plan."}],"balance_after":72874,"derivative":{"exercise_price":61.75,"exercise_date":"2011-02-11","expiration_date":"2018-02-10","underlying":"Common Stock","underlying_shares":72874},"source":{"system":"sec-edgar","filing":"0000200406-08-000038","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040608000038/edgar.xml","form_type":"4"}}],"next_cursor":"2008-02-13T22:39:02.000000Z,238703"}